Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gierula

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Diabetes & Vascular Disease Research|February 16, 2021
Diabetes, gender and deterioration in estimated glomerular filtration rate in patients with chronic heart failure: Ten-year prospective cohort studyJessica Kearney, Michael Drozd, Andrew Mn Walker, et al.
European Journal of Nutrition|August 20, 2018
Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failureRichard M Cubbon, Judith E Lowry, Michael Drozd, et al.
European Heart Journal Open|June 12, 2026
Prevalence and incidence of left ventricular systolic dysfunction and adverse outcomes in patients receiving <i>de novo</i> and replacement pacemaker therapy for bradycardiaNurul H Abdul Samad, John Gierula, Judith E Lowry, et al.
JACC. Heart Failure|December 12, 2017
Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart FailureJohn Gierula, Maria F Paton, Judith E Lowry, et al.
Pacing and Clinical Electrophysiology : PACE|August 12, 2020
Long-term performance of left ventricular leads in cardiac resynchronisation therapyPeysh A Patel, Ramesh Nadarajah, Noman Ali, et al.
ESC Heart Failure|September 14, 2020
Effect of disease-modifying agents and their association with mortality in multi-morbid patients with heart failure with reduced ejection fractionSam Straw, Melanie McGinlay, Samuel D Relton, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 5, 2022
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fractionSam Straw, Charlotte A Cole, Melanie McGinlay, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 14, 2021
Impact of QRS duration on left ventricular remodelling and survival in patients with heart failureSam Straw, Melanie McGinlay, John Gierula, et al.
Diabetes & Vascular Disease Research|March 3, 2022
Diabetes mellitus and the causes of hospitalisation in people with heart failureAnam Malik, Ellis Garland, Michael Drozd, et al.
Plos One|December 13, 2021
Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trialMaria F Paton, John Gierula, Judith E Lowry, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Diabetes & Vascular Disease Research|February 16, 2021
Diabetes, gender and deterioration in estimated glomerular filtration rate in patients with chronic heart failure: Ten-year prospective cohort studyJessica Kearney, Michael Drozd, Andrew Mn Walker, et al.
European Journal of Nutrition|August 20, 2018
Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failureRichard M Cubbon, Judith E Lowry, Michael Drozd, et al.
European Heart Journal Open|June 12, 2026
Prevalence and incidence of left ventricular systolic dysfunction and adverse outcomes in patients receiving <i>de novo</i> and replacement pacemaker therapy for bradycardiaNurul H Abdul Samad, John Gierula, Judith E Lowry, et al.
JACC. Heart Failure|December 12, 2017
Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart FailureJohn Gierula, Maria F Paton, Judith E Lowry, et al.
Pacing and Clinical Electrophysiology : PACE|August 12, 2020
Long-term performance of left ventricular leads in cardiac resynchronisation therapyPeysh A Patel, Ramesh Nadarajah, Noman Ali, et al.
ESC Heart Failure|September 14, 2020
Effect of disease-modifying agents and their association with mortality in multi-morbid patients with heart failure with reduced ejection fractionSam Straw, Melanie McGinlay, Samuel D Relton, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 5, 2022
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fractionSam Straw, Charlotte A Cole, Melanie McGinlay, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 14, 2021
Impact of QRS duration on left ventricular remodelling and survival in patients with heart failureSam Straw, Melanie McGinlay, John Gierula, et al.
Diabetes & Vascular Disease Research|March 3, 2022
Diabetes mellitus and the causes of hospitalisation in people with heart failureAnam Malik, Ellis Garland, Michael Drozd, et al.
Plos One|December 13, 2021
Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trialMaria F Paton, John Gierula, Judith E Lowry, et al.
Pageof 7